KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Total Current Liabilities (2016 - 2026)

Medtronic's Total Current Liabilities history spans 12 years, with the latest figure at $9.5 billion for Q1 2026.

  • For Q1 2026, Total Current Liabilities fell 19.81% year-over-year to $9.5 billion; the TTM value through Jan 2026 reached $9.5 billion, down 19.81%, while the annual FY2025 figure was $12.9 billion, 19.37% up from the prior year.
  • Total Current Liabilities for Q1 2026 was $9.5 billion at Medtronic, down from $9.9 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $14.5 billion in Q4 2022 and bottomed at $8.9 billion in Q1 2022.
  • The 5-year median for Total Current Liabilities is $10.8 billion (2024), against an average of $11.2 billion.
  • The largest annual shift saw Total Current Liabilities surged 85.38% in 2022 before it plummeted 35.6% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $14.5 billion in 2022, then crashed by 33.23% to $9.7 billion in 2023, then increased by 26.26% to $12.2 billion in 2024, then dropped by 18.53% to $9.9 billion in 2025, then fell by 4.43% to $9.5 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Total Current Liabilities are $9.5 billion (Q1 2026), $9.9 billion (Q4 2025), and $11.5 billion (Q3 2025).